Menu
E70.329

Oculocutaneous albinism, unspecified

Instruction Source: E70.329

Oculocutaneous albinism, unspecified

Instruction Source: E70.32

Oculocutaneous albinism

Excludes 1 (Mutually Exclusive)

  • Chediak-Higashi syndrome (E70.330)
  • Hermansky-Pudlak syndrome (E70.331)
Instruction Source: E70.3

Albinism

Instruction Source: E70

Disorders of aromatic amino-acid metabolism

Instruction Source: E70-E88

Metabolic disorders (E70-E88)

Excludes 1 (Mutually Exclusive)

  • 5-alpha-reductase deficiency (E29.1)
  • Marfan syndrome (Q87.4-)
  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)

Excludes 2 (Not Included Here)

  • Ehlers-Danlos syndromes (Q79.6-)
Instruction Source: E00-E89

Endocrine, nutritional and metabolic diseases

Excludes 1 (Mutually Exclusive)

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Clinical Notes

  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
← View E70.329 in Tabular List